MicroRNA-361-3p promotes human breast cancer cell viability by inhibiting the E2F1/P73 signalling pathway
Open Access
- 1 May 2020
- journal article
- retracted article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 125, 109994
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- NCBI GEO: archive for functional genomics data sets—updateNucleic Acids Research, 2012
- A panel of five circulating microRNAs as potential biomarkers for prostate cancerThe Prostate, 2012
- Translating DNA damage into cancer cell death—A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistanceDrug Resistance Updates, 2010
- MCPH1/BRIT1 cooperates with E2F1 in the activation of checkpoint, DNA repair and apoptosisEMBO Reports, 2008
- E2F1-induced apoptosis: turning killers into therapeuticsTrends in Molecular Medicine, 2006
- Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA TargetsCell, 2005
- Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAsNature Reviews Genetics, 2004
- bantam Encodes a Developmentally Regulated microRNA that Controls Cell Proliferation and Regulates the Proapoptotic Gene hid in DrosophilaCell, 2003
- E2F1 pathways to apoptosisFEBS Letters, 2002
- Unrestricted cell cycling and cancerNature Medicine, 1995